Calculation of the odds ratio for studies investigating the relationship between allogeneic blood transfusion and cancer recurrence or postoperative infection
Group . | Adverse outcome: cancer recurrence or postoperative infection . | Totals . | |
---|---|---|---|
Occurring . | Not occurring . | ||
Exposed to allogeneic transfusion* | a | b | a + b |
Not exposed to allogeneic transfusion† | c | d | c + d |
Totals | a + c | b + d | n‡ |
Group . | Adverse outcome: cancer recurrence or postoperative infection . | Totals . | |
---|---|---|---|
Occurring . | Not occurring . | ||
Exposed to allogeneic transfusion* | a | b | a + b |
Not exposed to allogeneic transfusion† | c | d | c + d |
Totals | a + c | b + d | n‡ |
Odds of an adverse outcome in those exposed to allogeneic transfusion: [a / (a + b)] / [b / (a + b)] = a / b | |||
Odds of an adverse outcome in those not exposed to allogeneic transfusion: [c / (c + d)] / [d / (c + d)] = c / d | |||
|
Odds of an adverse outcome in those exposed to allogeneic transfusion: [a / (a + b)] / [b / (a + b)] = a / b | |||
Odds of an adverse outcome in those not exposed to allogeneic transfusion: [c / (c + d)] / [d / (c + d)] = c / d | |||
|
Treatment arm (patients prospectively randomized to receive transfusion of allogeneic WBCs) in RCTs, or treatment group (patients having transfusion) in observational cohort studies.
Control arm (patients prospectively randomized to receive transfusion of autologous or WBC-reduced allogeneic RBCs) in RCTs, or control group (patients not having transfusion) in observational cohort studies.
n = a + b + c + d; a, b, c, and d are the 4 counts of a 2 × 2 contingency table.54